Hengrui Pharmaceuticals funding history / development milestones

定向增发,融资金额未公开

2017.03.01, 国药投资

定向增发,融资金额未公开

定向增发,融资金额未公开

2015.12.01, 中投公司

IPO上市,主板

2000.10.18,上交所

Note: collected from public online reports, for reference only.

People who follow Hengrui Pharmaceuticals also follow

Hengrui Pharmaceuticals Competitors (Similar Companies)

“To develop high-quality biologics that are accessible and affordable f”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“Continuously innovating to bring patients medicines that significantly”
“Seek and strive, protect and heal all beings”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Caring for life, safeguarding health”
“Dedicated to the research and development of molecularly targeted drug”
“Professional services for the entire clinical trial process of drug pr”
“Developing innovative drugs to improve human health”
“Technological innovation and commercial application of pharmaceutical ”
“One of the leading enterprises in the pharmaceutical industry”
“Helping partners successfully develop new drugs, reducing R&D costs an”
“A large traditional Chinese medicine enterprise integrating R&D, produ”
“Helping patients access more effective medicines sooner”
“A leading open-access capability and technology platform company for p”